Status
Conditions
Treatments
About
This study is designed to evaluate the feasibility and safety of axillary radiotherapy for early stage breast cancer with limited positive sentinel lymph nodes.
Full description
Randomized clinical trials have demonstrated that complete axillary lymph node dissection is not necessary in patients with 1-2 positive sentinel lymph nodes who undergo breast conserving surgery, whole breast irradiation, and systemic therapy. However, whether or not the regional lymph node should be irradiated and if radiation given, whether or not all levels of axillary lymph node and internal mammary and supraclavicular lymph node should be irradiated is unknown. The purpose of this study is to evaluate the feasibility and safety of axillary level I-II areas radiotherapy for early stage breast cancer with 1-2 positive sentinel lymph nodes and no further axillary lymph node dissection.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
475 participants in 1 patient group
Loading...
Central trial contact
Xiaoli Yu, MD.PhD; Zhaozhi Yang, MD.PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal